2022

1. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

   Frontiers in Oncology, Vol. 12

2. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

   Blood, Vol. 140, Núm. 26, pp. 2773-2787

3. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

   Blood, Vol. 139, Núm. 10, pp. 1588-1592

4. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

   American Journal of Hematology